Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Main Authors: | S. F. Jørgensen, M. E. Macpherson, T. Bjørnetrø, K. Holm, M. Kummen, A. Rashidi, A. E. Michelsen, T. Lekva, B. Halvorsen, M. Trøseid, T. E. Mollnes, R. K. Berge, A. Yndestad, T. Ueland, T. H. Karlsen, P. Aukrust, J. R. Hov, B. Fevang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-54117-6 |
Similar Items
-
Disturbed lipid profile in common variable immunodeficiency – a pathogenic loop of inflammation and metabolic disturbances
by: Silje F. Jorgensen, et al.
Published: (2023-07-01) -
Fatty Acids Composition and HIV Infection: Altered Levels of n-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression
by: Thor Ueland, et al.
Published: (2023-07-01) -
Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency
by: Ragnhild Øye Løken, et al.
Published: (2023-04-01) -
COMPLEX TREATMENT OF HELICOBACTER PYLORI INFECTION WITH RIFAXIMIN IN CHILDREN
by: A.A. Nizhevich, et al.
Published: (2009-11-01) -
COMPLEX TREATMENT OF HELICOBACTER PYLORI INFECTION WITH RIFAXIMIN IN CHILDREN
by: A.A. Nizhevich, et al.
Published: (2009-01-01)